News Notes

Cell Engineering at Hopkins Already a hub for stem cell research, the Johns Hopkins University School of Medicine has announced plans for a new center to focus on selecting and modifying human cells. Called the Institute for Cell Engineering (ICE), the 40,000 square foot building will be funded through a $58.5 million private, anonymously made donation. Hopkins faculty announced the new project at a January 30 press conference. "What we're interested in really is reprogramming cells and puttin

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Already a hub for stem cell research, the Johns Hopkins University School of Medicine has announced plans for a new center to focus on selecting and modifying human cells. Called the Institute for Cell Engineering (ICE), the 40,000 square foot building will be funded through a $58.5 million private, anonymously made donation. Hopkins faculty announced the new project at a January 30 press conference. "What we're interested in really is reprogramming cells and putting them back into the host," says Chi Dang, vice dean of research for the school of medicine. Projects at the ICE, which is slated to open in 2003, are to include the development of therapeutic cell transplants for neurodegenerative disease, spinal cord injury, diabetes, stroke, and heart failure. A previously garnered grant of $23.8 million from the state of Maryland will fund the construction of a new research building; ICE staff and equipment, funded exclusively by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies